about
Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner.Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trialPhase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maravirocSafety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trialMALDI Mass Spectrometry Imaging Reveals Heterogeneous Distribution of Tenofovir and Tenofovir Diphosphate in Colorectal Tissue of Subjects Receiving a Tenofovir-Containing EnemaDevelopment of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enemaTransgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men
P50
Q36106256-E18D3B32-67DD-44C4-9ECA-E7F747211BB9Q58587972-0F435F78-0994-4841-AFE1-CD972C462E3CQ58723423-F9CD79ED-CAF5-4169-96EF-03823A6B892EQ59126569-18059E13-BCCF-4D81-A858-7803C0B9CFE1Q59356168-CFD3989A-8938-433C-92EE-50EBBC516FEAQ88869972-BD9498C8-A202-4321-995B-6807C6D85BACQ91137956-9ABD079F-E7ED-466C-927A-510613C3C892
P50
description
researcher ORCID ID = 0000-0002-5696-8665
@en
wetenschapper
@nl
name
Craig W Hendrix
@ast
Craig W Hendrix
@en
Craig W Hendrix
@nl
type
label
Craig W Hendrix
@ast
Craig W Hendrix
@en
Craig W Hendrix
@nl
prefLabel
Craig W Hendrix
@ast
Craig W Hendrix
@en
Craig W Hendrix
@nl
P106
P31
P496
0000-0002-5696-8665